Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of determining responsiveness to anti-TNFα therapy in inflammatory bowel disease

Methods of determining responsiveness to anti-TNFα therapy in inflammatory bowel disease

US Patent 12084722 · Granted Sep 10, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and systems for selection and treatment of patients with inflammatory di2025
Signature of TL1A (TNFSF15) signaling pathway2025
Methods of treating refractory inflammatory disease using transcriptomic and gen2025
Diagnosis and treatment of inflammatory bowel disease2024
Diagnosis and treatment of inflammatory bowel disease2024
Diagnosis and treatment of inflammatory bowel disease2024
Diagnosis and treatment of inflammatory bowel disease2024
Kit comprising contiguous nucleobases, including position 76, of RS57459942024
Humanized antibodies to TNF-like ligand 1A (TL1A) and uses thereof2024
Systems and methods for growth of intestinal cells in microfluidic devices2022
Optimized anti-TL1A antibodies2022
Mitigation and reversal of intestinal fibrosis and inflammation by inhibition of2022